INS and type 2 diabetes mellitus: Fan et al. in 2015 showed that vildagliptin increased apelin levels in T2DM patients [103], and they concluded that 12 weeks of vildagliptin therapy normalized glycemic indices and improved insulin sensitivity due to the rise in apelin levels [103].